Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers

NCT03234478 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT03234478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03234478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Observational
Overall status
Completed
Start date
July 1, 2017
Completion date
June 30, 2024
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive decline, gba gene mutation, genetic predisposition, parkinson, parkinson disease